Cargando…
EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence
BACKGROUND: Glioblastoma multiforme (GBM) is the most malignant central nervous system tumor. Alkylating agent, temozolomide (TMZ), is currently the first-line chemotherapeutic agent for GBM. However, the sensitivity of GBM cells to TMZ is affected by many factors. And, several clinic trials, includ...
Autores principales: | Li, Li, Huang, Yulun, Gao, Yuge, Shi, Tengfei, Xu, Yunyun, Li, Huini, Hyytiäinen, Marko, Keski-Oja, Jorma, Jiang, Qiuying, Hu, Yizhou, Du, Zhimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280426/ https://www.ncbi.nlm.nih.gov/pubmed/30514230 http://dx.doi.org/10.1186/s12885-018-5056-4 |
Ejemplares similares
-
NETRIN-4 Protects Glioblastoma Cells FROM Temozolomide Induced Senescence
por: Li, Li, et al.
Publicado: (2013) -
Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness
por: Ylivinkka, Irene, et al.
Publicado: (2017) -
Latent TGF-β binding protein LTBP-2 decreases fibroblast adhesion to fibronectin
por: Hyytiäinen, Marko, et al.
Publicado: (2003) -
Genetic variations in EGF and EGFR and glioblastoma outcome
por: Sjöström, Sara, et al.
Publicado: (2010) -
Differential Expression Patterns of EGF, EGFR, and ERBB4 in Nasal Polyp Epithelium
por: Duan, Chen, et al.
Publicado: (2016)